Gallic Acid Tailoring Surface Functionalities of Plasma-Polymerized Allylamine-Coated 316L SS to Selectively Direct Vascular Endothelial and Smooth Muscle Cell Fate for Enhanced Endothelialization
Source abstract
Abstract
The creation of a platform for enhanced vascular endothelia cell (VEC) growth while suppressing vascular smooth muscle cell (VSMC) proliferation offers possibility for advanced coatings of vascular stents. Gallic acid (GA), a chemically unique phenolic acid with important biological functions, presents benefits to the cardiovascular disease therapy because of its superior antioxidant effect and a selectivity to support the growth of ECs more than SMCs. In this study, GA was explored to tailor such a multifunctional stent surface combined with plasma polymerization technique. On the basis of the chemical coupling reaction, GA was bound to an amine-group-rich plasma-polymerized allylamine (PPAam) coating. The GA-functionalized PPAam (GA-PPAam) surface created a favorable microenvironment to obtain high ECs and SMCs selectivity. The GA-PPAam coating showed remarkable enhancement in the adhesion, viability, proliferation, migration, and release of nitric oxide (NO) of human umbilical vein endothelial cells (HUVECs). The GA-PPAam coating also resulted in remarkable inhibition effect on human umbilical artery smooth muscle cell (HUASMC) adhesion and proliferation. These striking findings may provide a guide for designing the new generation of multifunctional vascular devices.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Coronary Interventions and Diagnostics · Aortic aneurysm repair treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Key Laboratory of Advanced Technology for Materials of Education Ministry, ‡The Institute of Biomaterials and Surface Engineering, School of Materials Science and Engineering, and §Laboratory of Biosensing and MicroMechatronics, Southwest Jiaotong University, Chengdu 610031, China
References (64)
Show source-provided references
1. Shuchman M. N. · New Engl. J. Med. · 2006 · 355 · 194910.1056/NEJMp068234 ↗
2. Tsimikas S. · J. Am. Coll. Cardiol. · 2006 · 47 · 211210.1016/j.jacc.2006.03.019 ↗
3. Zilberman M. · Annu. Rev. Biomed. Eng. · 2006 · 8 · 15310.1146/annurev.bioeng.8.013106.151418 ↗
4. Eisenberg M. J. · Am. J. Cardiol. · 2006 · 98 · 37510.1016/j.amjcard.2006.02.042 ↗
5. Tsuchida K. · Am. J. Cardiol. · 2007 · 99 · 60710.1016/j.amjcard.2006.09.107 ↗
6. Cutlip D. E. · Circulation · 2001 · 103 · 196710.1161/01.CIR.103.15.1967 ↗
7. Finn A. V. · Circulation · 2007 · 115 · 243510.1161/CIRCULATIONAHA.107.693739 ↗
8. Kerdjoudj H. · Adv. Funct. Mater. · 2007 · 17 · 266710.1002/adfm.200600795 ↗
9. Pernagallo S. · Adv. Healthcare Mater. · 2012 · 1 · 64610.1002/adhm.201200130 ↗
10. Yang Z. L. · Adv. Healthcare Mater. · 2012 · 1 · 54810.1002/adhm.201200073 ↗
11. Müller S. · Adv. Funct. Mater · 2008 · 18 · 176710.1002/adfm.200701233 ↗
12. Yin Y. · Biomaterials · 2009 · 30 · 167510.1016/j.biomaterials.2008.11.009 ↗
13. Yin M. · Biomaterials · 2009 · 30 · 276410.1016/j.biomaterials.2009.01.039 ↗
14. Peng L. L. · Biomaterials · 2009 · 30 · 126810.1016/j.biomaterials.2008.11.012 ↗
15. Smith B. S. · J. Biomed. Mater. Res. · 2010 · 95 · 35010.1002/jbm.a.32853 ↗
16. Waterhouse A. · Biomaterials · 2010 · 31 · 833210.1016/j.biomaterials.2010.07.062 ↗
17. Yang Z. L. · Biomaterials · 2010 · 31 · 207210.1016/j.biomaterials.2009.11.091 ↗
18. Waterhouse A. · Biomaterials · 2012 · 33 · 798410.1016/j.biomaterials.2012.07.059 ↗
19. Stangl V. · Cardiovasc. Res. · 2007 · 73 · 34810.1016/j.cardiores.2006.08.022 ↗
20. Ho C. T. · Prev. Med. · 1992 · 21 · 52010.1016/0091-7435(92)90059-Q ↗
21. Caccetta R. A. A. · Free Radical Biol. Med. · 2001 · 30 · 63610.1016/S0891-5849(00)00497-4 ↗
22. Kang M. S. · J. Microbiol. · 2008 · 46 · 74410.1007/s12275-008-0235-7 ↗
23. Kratz J. M. · Biol. Pharm. Bull. · 2008 · 31 · 90310.1248/bpb.31.903 ↗
24. Kim S. H. · Toxicol. Sci. · 2006 · 91 · 12310.1093/toxsci/kfj063 ↗
25. Urizzi P. · J. Chim. Phys. · 1999 · 96 · 11010.1051/jcp:1999117 ↗
26. Chen H. M. · Cancer Lett. · 2009 · 286 · 16110.1016/j.canlet.2009.05.040 ↗
27. Inoue M. · Biol. Pharm. Bull. · 2000 · 23 · 115310.1248/bpb.23.1153 ↗
28. Qiu X. B. · Heart Vessels · 2000 · 15 · 9010.1007/s003800070038 ↗
29. Inoue M. · Biol. Pharm. Bull. · 1995 · 18 · 152610.1248/bpb.18.1526 ↗
30. Cocks T. M. · J. Cell. Physiol. · 1985 · 123 · 31010.1002/jcp.1041230304 ↗
31. Kubota Y. · Life Sci. · 2001 · 69 · 232710.1016/S0024-3205(01)01303-0 ↗
32. Cheng X. W. · Arterioscler. Thromb. Vasc. Biol. · 2005 · 25 · 186410.1161/01.ATV.0000179675.49619.9b ↗
33. Isemura M. · Biofactors · 2000 · 13 · 8110.1002/biof.5520130114 ↗
34. Sachinidis A. · FASEB J. · 2002 · 16 · 89310.1096/fj.01-0799fje ↗
35. Kim D. W. · Heart Vessels · 2004 · 19 · 242
36. Lu L. H. · Br. J. Pharmacol. · 1998 · 24 · 122710.1038/sj.bjp.0701912 ↗
37. Chyu K. Y. · Circulation · 2004 · 109 · 244810.1161/01.CIR.0000128034.70732.C2 ↗
38. Yang Z. L. · Plasma Process Polym. · 2009 · 6 · 49810.1002/ppap.200800195 ↗
39. Yang Z. L. · Biomaterials · 2012 · 33 · 661510.1016/j.biomaterials.2012.06.055 ↗
40. Yang Z. L. · Plasma Process Polym. · 2011 · 8 · 20810.1002/ppap.201000111 ↗
41. Hersel U. · Biomaterials · 2003 · 24 · 438210.1016/S0142-9612(03)00343-0 ↗
42. Tanaka M. · J. Nanosci. Nanotechnol. · 2007 · 7 · 76310.1166/jnn.2007.514 ↗
43. McGrath J. L. · Proc. Natl. Acad. Sci. U.S.A. · 2000 · 97 · 653210.1073/pnas.100023397 ↗
44. Puliafitoa A. · Proc. Natl. Acad. Sci. U.S.A. · 2012 · 17 · 73910.1073/pnas.1007809109 ↗
45. Avci-Adali M. · Biotechnol Adv. · 2010 · 28 · 11910.1016/j.biotechadv.2009.10.005 ↗
46. Yang Z. L. · Macromol. Biosci. · 2011 · 11 · 79710.1002/mabi.201000474 ↗
47. McCormick C. · Biochem. Soc. Trans. · 2007 · 35 · 91010.1042/BST0350910 ↗
48. Sneddon J. M. · Proc. Natl. Acad. Sci. U.S.A. · 1988 · 85 · 280010.1073/pnas.85.8.2800 ↗
49. Garas S. M. · Pharmacol. Ther. · 2001 · 92 · 16510.1016/S0163-7258(01)00168-1 ↗
50. Rajagopal V. · Am. J. Med. · 2003 · 115 · 54710.1016/S0002-9343(03)00477-7 ↗
51. Bennett M. R. · Pharmacol. Ther. · 2001 · 91 · 14910.1016/S0163-7258(01)00153-X ↗
52. Huisman A. · J. Nutr. Biochem. · 2004 · 15 · 42610.1016/j.jnutbio.2004.01.006 ↗
53. Huang Y. · Biochim. Biophys. Acta · 1999 · 1427 · 32210.1016/S0304-4165(99)00034-3 ↗
54. Benito S. · Br. J. Pharmacol. · 2002 · 135 · 91010.1038/sj.bjp.0704534 ↗
55. Furchgott R. F. · Circ. Res. · 1983 · 53 · 55710.1161/01.RES.53.5.557 ↗
56. Yang H. L. · J. Ethnopharmacol. · 2011 · 137 · 66910.1016/j.jep.2011.06.017 ↗
57. Ku S. H. · Biomaterials · 2010 · 31 · 253510.1016/j.biomaterials.2009.12.020 ↗
58. Rodriguez S. K. · Int. J. Cancer · 2006 · 118 · 163510.1002/ijc.21545 ↗
59. Han D. W. · Biochem. Biopharm. Res. Commun. · 2006 · 345 · 14810.1016/j.bbrc.2006.04.072 ↗
60. Kim C. H. · Arch. Biochem. Biophys. · 2005 · 435 · 26410.1016/j.abb.2004.12.022 ↗
61. Aoki J. · J. Am. Coll. Cardiol. · 2005 · 45 · 157410.1016/j.jacc.2005.01.048 ↗
62. Hill J. M. · New Engl. J. Med. · 2003 · 348 · 59310.1056/NEJMoa022287 ↗
63. Ceylan H. · Biomaterials · 2011 · 32 · 879710.1016/j.biomaterials.2011.08.018 ↗
64. Wei Y. · Biomaterials · 2013 · 34 · 258810.1016/j.biomaterials.2012.12.036 ↗